A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195. (Record no. 24909382)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01971 a2200577 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517032906.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201605s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1573-0646 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s10637-015-0252-4 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Eigl, B J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20160512 |
| 245 00 - TITLE STATEMENT | |
| Title | A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Investigational new drugs |
| Date of publication, distribution, etc. | Aug 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 969-76 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzimidazoles |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Histone Deacetylase Inhibitors |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kallikreins |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplastic Cells, Circulating |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | PTEN Phosphohydrolase |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prostate-Specific Antigen |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prostatic Neoplasms, Castration-Resistant |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Serine Endopeptidases |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Trans-Activators |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transcriptional Regulator ERG |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | North, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Winquist, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Finch, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wood, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sridhar, S S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Powers, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Good, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sharma, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Squire, J A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bazov, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jamaspishvili, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cox, M E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bradbury, P A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eisenhauer, E A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chi, K N |
| 773 0# - HOST ITEM ENTRY | |
| Title | Investigational new drugs |
| Related parts | vol. 33 |
| -- | no. 4 |
| -- | p. 969-76 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s10637-015-0252-4">https://doi.org/10.1007/s10637-015-0252-4</a> |
| Public note | Available from publisher's website |
No items available.